Our partner is dedicated to developing treatments for allergic and inflammatory diseases, focusing on targeting specific immune pathways. Their goal is to address unmet medical needs and improve patient outcomes through innovative therapies that reduce inflammation and enhance disease control.

This executive hire was responsible for successful completion of pre-BLA meetings and the company's module 3. They led teams with regulatory CMC responsibility for support of development, registration and life cycle support, and CMC regulatory strategy for the United States and EU. They were the key interface between Regulatory and the Technical Operations functions while partnering with regulatory support functions.